A Clinical Trial of MK-1403 in Healthy Participants (MK-1403-007)

NCT07677163 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: MK-1403 formulation (FM) 1 + additive
DRUG: MK-1403 FM2 + additive

Sponsor

Merck Sharp & Dohme LLC